La cadena de opciones muestra datos clave de las opciones de acciones de Royalty Management Hldgs a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Royalty Management Hldgs..

Royalty Management Hldgs (NASDAQ:RMCO) Bolsa, Cadena de Opciones

Royalty Management Hldgs

Royalty Management Holding Corp formed to invest or purchase assets that have current or near-term income to provide the company with accretive cash flow from which it can reinvest in new assets or expand cash flow from existing assets. These assets typically are natural resources assets (including real estate and mining permits), patents, intellectual property, and emerging technologies.

Royalty Management Holding Corporation - Class A Common Stock

Royalty Management Holding Corp

Royalty Management Holding Corporation - Warrant

News

Guidance

Sprinklr Sees Q1 Revenues Between $201.5M-$202.5M Vs. $200.41M Estimate, With Adjusted EPS Of $0.10 Vs. $0.08 Estimate

The chairperson of Alibaba Group Holding ADR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), Joseph Tsai acknowledged that everyone around the world is concerned about the ongoing tariff battle between the economic powerhouses of the world.
What Happened: While speaking at CNBC&#8217;s event Converge Live, in Singapore, Tsai responded to a question on tariff imposition by the Donald Trump administration and said that &#8220;Everyone is concerned about tariffs.&#8221;
He highlighted that the Chinese multinational technology company sells $50 billion worth of American products on its platform to Chinese consumers every year. On the other hand, about $30 billion worth of European products are also sold annually.
"I think the Trump administration will want to have more American companies doing business in China and making money there," he said, adding that it was ultimately between the global leaders to meet and decide on the future course of these protectionist policies.
Furthermore, he suggested if Trump&#8217;s wider tariff approach was just a bargaining chip, there was still a likelihood of seeing specific tariffs on Chinese electric vehicles. Tsai added that it could be a move to safeguard the American auto industry from potential competition.
See Also: <a href="https://www.benzinga.com/25/03/44269729/debt-over-equity-billionaire-howard-marks-endorses-credit-investments-amid-shifting-investor-focus-and-market-correction">Billionaire Howard Marks Prefers Credit Over Equity Amid Falling Market: &#8216;Yields Implies Higher Returns From Credit Than The S&amp;P 500&#8217;</a>
Why It Matters: On Tuesday afternoon, President Trump unexpectedly reversed his decision to double tariffs on Canadian steel and aluminum to 50%, just hours after announcing the increase. The abrupt policy change, which rattled financial markets, followed Canada&#8217;s withdrawal of plans for a 25% surcharge on electricity.
Additionally, as Trump&#8217;s tariffs on steel and aluminum imports go into effect, the European Union announced on Wednesday that it will retaliate by imposing levies of 26 billion euros or $28.33 billion on U.S. goods beginning in April.
Price Action: The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, rose in premarket on Wednesday. The SPY was up 0.73% to $560.00, and the QQQ also advanced 0.83% to $475.51, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/25/03/44245897/billionaire-investor-ron-baron-reacts-to-nasdaq-sp-selloff-the-stock-prices-cant-believe-how-cheap-they-are" target="_blank" rel="noreferrer noopener">Billionaire Investor Ron Baron Reacts To Nasdaq, S&amp;P Selloff: ‘The Stock Prices…Can't Believe How Cheap They Are'</a></li>
</ul>
Photo courtesy: Shutterstock

Equities

Government

Global

Economics

Markets

BABA

Alibaba's Joseph Tsai Says 'Everyone Is Concerned About Tariffs,' As He Expects Levies On Chinese EVs

HC Wainwright &amp; Co. analyst Andres Maldonado reiterates Corbus Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) with a Buy and lowers the price target from $75 to $50.

Price Target

Reiteration

Analyst Ratings

CRBP

HC Wainwright & Co. Reiterates Buy on Corbus Pharmaceuticals, Lowers Price Target to $50

United Homes Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UHG#NASDAQ">UHG</a>) reported quarterly earnings of $0.01 per share. This is a 100.72 percent increase over losses of $(1.38) per share from the same period last year. The company reported $134.81 million in sales this quarter. This is a 15.39 percent increase over sales of $116.83 million the same period last year.

Earnings

United Homes Gr Q4 EPS $0.01 Up From $(1.38) YoY, Sales $134.81M Up From $116.83M YoY

Barrington Research analyst Vincent Colicchio maintains Barrett Business Services (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBSI#NASDAQ">BBSI</a>) with a Outperform and maintains $45 price target.

BBSI

Barrington Research Maintains Outperform on Barrett Business Services, Maintains $45 Price Target

OPRX

OptimizeRx Sees FY25 Adjusted EBITDA Of At Least $12M

Sagimet Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGMT#NASDAQ">SGMT</a>) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $(0.60) by 16.67 percent. This is a 47.06 percent decrease over losses of $(0.34) per share from the same period last year.

Earnings Beats

SGMT

Sagimet Biosciences Q4 2024 GAAP EPS $(0.50) Beats $(0.60) Estimate

OptimizeRx Sees FY25 Revenue Of At Least $100M Vs. $99.646M Est.

Needham analyst Matt Dezort reiterates Telos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLS#NASDAQ">TLS</a>) from Hold to Hold.

Needham Reiterates Hold on Telosto Hold

THTX

Theratechnologies Presented Data From A Real-world, Observational, Registry Study Demonstrating The Efficacy And Safety Of Ibalizumab In Reducing HIV RNA To Undetectable Levels In Heavily Treatment-experienced Patients With Multidrug Resistant HIV

Sprinklr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CXM#NYSE">CXM</a>) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.07 by 42.86 percent. This is a 16.67 percent decrease over earnings of $0.12 per share from the same period last year. The company reported quarterly sales of $202.539 million which beat the analyst consensus estimate of $200.579 million by 0.98 percent. This is a 4.29 percent increase over sales of $194.207 million the same period last year.

Sprinklr Q4 2025 Adj. EPS $0.10 Beats $0.07 Estimate, Sales $202.539M Beat $200.579M Estimate

<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="900" height="600" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/12030007/IMG_0791.jpeg" alt="" class="wp-image-7674" style="width:900px;height:auto" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/12030007/IMG_0791.jpeg 900w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/12030007/IMG_0791-300x200.jpeg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/03/12030007/IMG_0791-768x512.jpeg 768w" sizes="(max-width: 900px) 100vw, 900px" /></figure>
The logistics arm of e-commerce giant JD.com reported its 2024 revenue grew nearly 10%, as external customers contributed 70% of the total
JD Logistics Inc.&nbsp;(2618.HK) reported 9.7% revenue growth and a record profit last year, as it diversified its customer base beyond its parent, e-commerce giant JD.com, and boosted its margins through steady technology upgrades and other efficiencies.
The company reported revenue of 182.8 billion yuan ($25.6 billion) for 2024, with external customers supplying 127.8 billion yuan, or about 70% of its total, according to&nbsp;<a href="https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0306/2025030600879.pdf">its results</a>&nbsp;released on last Friday. It recorded a non-IFRS annual profit of 7.92 billion yuan, nearly triple the 2.76 billion yuan a year earlier, on greater efficiencies as it upgraded its technology-driven integrated supply chain (ISC) solutions. Its non-IFRS margin rose from 1.7% in 2023 to 4.3% last year. Both the profit and margin were the company's highest since its listing in 2021.
On a quarterly basis, JD Logistics' fourth quarter revenue rose 10.4% year-on-year to 52.1 billion yuan, while its non-IFRS profit rose 23.4% to 2.2 billion yuan, improving for an eighth consecutive quarter.
"Over the past year, we have further consolidated our differentiated competitive advantages centered on ISC solutions and high-quality logistics services by continuously optimizing warehouse network deployment, advancing technological innovations, and enhancing operational efficiency," said CEO Hu Wei on the company's earnings call.
JD Logistics said it has used its industry-specific ISC management services to help its corporate customers across a range of industries, including home appliances, furniture and apparel, to reduce costs and enhance their efficiency by optimizing inventory management, streamlining resource allocation and reducing operating costs.
Revenue from ISC customers last year reached 87.4 billion yuan. Its external ISC customer base totaled 80,703 up 8% from a year earlier.
In 2024, the company said it fully upgraded its digital supply chain technology ecosystem with its "JD Logistics Super Brain", which integrates technologies including AI, big data, and operations research into diverse logistics processes.
At the end of last year, JD Logistics operated a network of over 100 warehouses for its international business with an aggregate gross floor area of over 1 million square meters. Its overseas warehouse network now covers 19 countries and regions.
In its global business, JD Logistics said last year it was supporting a leading Chinese new energy vehicle (NEV) brand with its China-Europe trunk line services. It also said it was supporting another automotive brand with its full cross-border services, including customs clearance, warehousing and distribution in the Middle East.
The company continued to build up its network infrastructure last year to expand its freight delivery and international express delivery services to grab a bigger share of the global e-commerce market. As part of its global build-out, it recently announced that it opened its third warehouse in Poland on Tuesday this week.
JD Logistics was the second unit of JD.com for a separate listing in 2021, raising HK$24.1 billion ($3.1 billion). It was originally set up as JD.com's in-house logistics department in 2007 and has grown since then to become one of the largest players in China's ISC logistics services industry.&nbsp;

Asia

JD.COM's Logistics Unit Triples Annual Profit On Supply Chain Upgrades

OptimizeRx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPRX#NASDAQ">OPRX</a>) reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $0.27 by 11.11 percent. This is a 15.38 percent increase over earnings of $0.26 per share from the same period last year. The company reported quarterly sales of $32.32 million which beat the analyst consensus estimate of $30.36 million by 6.45 percent. This is a 13.79 percent increase over sales of $28.40 million the same period last year.

OptimizeRx Q4 Adj $0.30 Beats $0.27 Estimate, Sales $32.32M Beat $30.36M Estimate

D. Boral Capital analyst Jason Kolbert maintains VolitionRX (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VNRX#AMEX">VNRX</a>) with a Buy and maintains $5 price target.

VNRX

D. Boral Capital Maintains Buy on VolitionRX, Maintains $5 Price Target

Evercore ISI Group analyst Cory Kasimov initiates coverage on Summit Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>) with a Outperform rating and announces Price Target of $30.

Initiation

SMMT

Evercore ISI Group Initiates Coverage On Summit Therapeutics with Outperform Rating, Announces Price Target of $30

HC Wainwright &amp; Co. analyst Andres Maldonado reiterates Werewolf Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOWL#NASDAQ">HOWL</a>) with a Buy and maintains $15 price target.

HOWL

HC Wainwright & Co. Reiterates Buy on Werewolf Therapeutics, Maintains $15 Price Target

BlackBerry Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) division&nbsp;QNX introduced a Functional Safety (FuSa) platform designed<a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/ac44269547/qnx-launches-functional-safety-platform-to-consolidate-safety-systems-and-ai-workloads" rel="noreferrer noopener"> for advanced robotic systems</a>.
In collaboration with Intel and NexCOBOT, the platform integrates both robotic and safety controls onto a single NexCOBOT board.
This consolidation is intended to help manufacturers and developers reduce costs, minimize power consumption, enhance thermal efficiency, and lower the risk of hardware failures.
This advanced platform is designed to address the increasing need for integrated, safety-certified solutions in industrial automation and robotics.
Optimized for AI-powered environments, it delivers enhanced computing power and virtualization, supporting AI-driven vision systems, real-time motion control, and other critical robotic functions while adhering to safety certification standards.
Grant Courville, SVP, Products and Strategy at QNX, said, &#8220;Based, on our proven track record in delivering safety-certified solutions, developers know that our platform meets the standards of safety and performance.&#8221;
&#8221;Our continued collaboration with Intel and NexCOBOT means we are able to leverage our expertise to create a unified solution that addresses the complex demands of modern robotics and industrial automation.&#8221;
Yesterday, QNX disclosed an expanded collaboration with&nbsp;Advanced Micro Devices&nbsp;to enhance performance in&nbsp;robotic <a target="_blank" href="https://www.benzinga.com/25/03/44245429/blackberry-qnx-expands-support-for-amd-platforms-enhancing-robotic-and-embedded-applications" rel="noreferrer noopener">systems and embedded devices</a>.
Investors can gain exposure to the stock via&nbsp;SPDR S&amp;P Kensho Future Security ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FITE#NYSE">FITE</a>).
Price Action: BB shares are up 1.14% at $4.42 premarket at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/mid-cap/25/03/44261077/dan-loeb-pulls-the-plug-on-bath-body-works-stake-as-sales-decline" target="_blank" rel="noreferrer noopener">Dan Loeb Pulls Plug On Bath &amp; Body Works Stake As Sales Decline</a></li>
</ul>
Image via Shutterstock.

Large Cap

Contracts

FITE

BlackBerry QNX Introduces All-in-One Functional Safety Platform for Smarter, Safer Robotics

HC Wainwright &amp; Co. analyst Andres Maldonado reiterates Mural Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MURA#NASDAQ">MURA</a>) with a Buy and maintains $18 price target.

MURA

HC Wainwright & Co. Reiterates Buy on Mural Oncology, Maintains $18 Price Target

HC Wainwright &amp; Co. analyst Matthew Caufield reiterates Zenas BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBIO#NASDAQ">ZBIO</a>) with a Buy and maintains $30 price target.

ZBIO

HC Wainwright & Co. Reiterates Buy on Zenas BioPharma, Maintains $30 Price Target

Telsey Advisory Group analyst Dana Telsey maintains Stitch Fix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFIX#NASDAQ">SFIX</a>) with a Market Perform and maintains $6 price target.

Comments

Royalty Management Hldgs

Royalty Management Hldgs (RMCO) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL